Log in to your IBTimes Account

close
ID
Password

Army, Hopkins collaborate on biodefense research



By DAVID DISHNEAU
12 May 2008 @ 05:56 pm EST

The Army and Johns Hopkins University announced a deal Monday enabling biotechnology graduate students to work with scientists at the military's premier biological weapons defense laboratory at Fort Detrick in Frederick, Md., at the Army's expense.

Related Topic

Get stories by e-mail on this topic.

E-mail:

The students will be employed under the Army's Student Career Experience Program and will be eligible for Army reimbursement of their tuition at Baltimore-based Johns Hopkins, school officials said.

The reimbursement agreement is a first for U.S. Army Research Institute of Infections Disease, which has had graduate students, including some from Hopkins, working in its labs for years, institute spokeswoman Caree Vander Linden said.

At least two fellowships will be offered yearly, starting this fall, to students with a biodefense concentration within the biotechnology master's degree program. They will work at USAMRIDD, where scientists study some of the world's most dangerous pathogens, including anthrax, the Ebola virus and botulinum neurotoxin.

"USAMRIID is very excited about sponsoring these master's students and offering them the opportunity to work at USAMRIID on vaccines and therapeutics against extremely interesting pathogens," said Peter Hobart, the institute's science director.

The students will most likely work in biosafety level 3 labs and possibly BSL-4 labs, reserved for the most virulent agents, said Patrick Cummings, senior associate chairman of Hopkins' advanced biotechnology studies program. Some security clearance will be required, Cummings and Associate Chair Kristina Obom said in an e-mail.

Program Chairman Richard McCarty said in a prepared statement that the five-year deal offers invaluable educational opportunities.

"We hope it will lead to future interactions and joint scientific research between our respective faculty and scientists," McCarty said.

USAMRIID develops vaccines, drugs and tests to protect soldiers, but much of what it produces is also applied to civilian medicine. Just last month, scientists from USAMRIID and the Brookhaven National Laboratory in Upton, N.Y., announced progress toward an antidote to the most potent form of botulinum neurotoxin, responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles.

Biodefense work at Johns Hopkins historically has focused on preparedness and policy questions rather than lab work. The school was home to the Center for Civilian Biodefense Strategies from 1998 to 2003, when that organization moved to the University of Pittsburgh Medical Center.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

More News

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Politics & Policy
France's central bank announced Friday that it has fined Societe Generale $6.3 million for "serious shortcomings" in its internal controls that led to ne...
Two supervisors at an Iowa meatpacking plant that was raided by federal immigration agents in May were arrested and charged with encouraging people to li...
It was a family Fourth of July for Democrat Barack Obama as his wife, daughters, sister and other relatives helped him make an Independence Day play for ...

Advertisement
Latest Investing Research Reports

Find the most up to date research from leading investment firms to make the most informed investing decisions

Corporate Website Design

Professional Website Design For Corporate - Get a Free Quote Today

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives